Adishwar Rao

ORCID: 0000-0003-1744-4217
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac, Anesthesia and Surgical Outcomes
  • Mechanical Circulatory Support Devices
  • Pulmonary Hypertension Research and Treatments
  • Pleural and Pulmonary Diseases
  • Pneumothorax, Barotrauma, Emphysema
  • Occupational and environmental lung diseases
  • Immune Cell Function and Interaction
  • Cardiac Valve Diseases and Treatments
  • CAR-T cell therapy research
  • COVID-19 Clinical Research Studies
  • Sepsis Diagnosis and Treatment
  • Intensive Care Unit Cognitive Disorders
  • Atrial Fibrillation Management and Outcomes
  • Pancreatitis Pathology and Treatment
  • Venous Thromboembolism Diagnosis and Management
  • Peripheral Artery Disease Management
  • Long-Term Effects of COVID-19
  • Cardiac Structural Anomalies and Repair
  • COVID-19 and healthcare impacts
  • Healthcare Policy and Management
  • Lung Cancer Diagnosis and Treatment
  • Frailty in Older Adults
  • Legionella and Acanthamoeba research
  • Microscopic Colitis
  • Lymphoma Diagnosis and Treatment

Guthrie Robert Packer Hospital
2024-2025

The University of Texas Health Science Center at Houston
2023-2025

SUNY Upstate Medical University
2024-2025

The University of Texas MD Anderson Cancer Center
2024-2025

Guthrie Foundation
2024

Netaji Subhash Chandra Bose Medical College
2023

Kakatiya University
2022

γδ T cells play an important role in disease control acute myeloid leukemia (AML) and have become emerging area of therapeutic interest. These represent a minor population lymphocytes with intrinsic abilities to recognize antigens major histocompatibility complex-independent manner functionally straddle the innate adaptive immunity interface. AML shows high expression phosphoantigens UL-16 binding proteins that activate Vδ2 Vδ1 subtypes cells, respectively, leading cell-mediated...

10.1136/jitc-2023-007981 article EN cc-by-nc Journal for ImmunoTherapy of Cancer 2024-02-01

Background: Cardiogenic shock (CS) is one of the leading causes death in patients with myocardial infarction, myocarditis, and congestive heart failure. The utilization patterns specialist palliative care (PC) consultation these are currently unknown. Objectives: To determine PC CS overall comorbidities that population. Methods: Review 2020 National Inpatient Sample identified 6,471,165 hospitalizations which 38,531 were hospitalized via International Classification Diseases, Tenth Revision,...

10.1089/jpm.2024.0116 article EN Journal of Palliative Medicine 2025-01-09

Abstract Induced pluripotent stem cell (iPSC)–derived natural killer (NK) cells offer an opportunity for a standardized, off‐the‐shelf treatment with the potential to treat wider population of acute myeloid leukaemia (AML) patients than current standard care. FT538 iPSC‐NKs express high‐affinity, noncleavable CD16 maximize antibody dependent cellular cytotoxicity, CD38 knockout improve metabolic fitness, and IL‐15/IL‐15 receptor fusion preventing need cytokine administration, main source...

10.1111/jcmm.70169 article EN cc-by Journal of Cellular and Molecular Medicine 2025-01-01

Background: Malignant pleural effusion (MPE) affects approximately 150,000 patients in the United States each year and usually signifies advanced-stage cancer. The optimal treatment remains a challenge but indwelling catheters (IPC) offer several advantages may help achieve spontaneous pleurodesis (SP) some patients. Objectives: We aim to investigate predictors of SP among with MPE, particularly resource-limited community-based safety net hospital. Design: This is retrospective cohort study...

10.1177/17534666251318844 article EN cc-by-nc Therapeutic Advances in Respiratory Disease 2025-01-01
Coming Soon ...